Quest Partners LLC Biocryst Pharmaceuticals Inc Transaction History
Quest Partners LLC
- $1.02 Trillion
- Q2 2025
A detailed history of Quest Partners LLC transactions in Biocryst Pharmaceuticals Inc stock. As of the latest transaction made, Quest Partners LLC holds 85,353 shares of BCRX stock, worth $712,697. This represents 0.08% of its overall portfolio holdings.
Number of Shares
85,353
Previous 62,646
36.25%
Holding current value
$712,697
Previous $470 Million
62.77%
% of portfolio
0.08%
Previous 0.05%
Shares
4 transactions
Others Institutions Holding BCRX
# of Institutions
299Shares Held
177MCall Options Held
721KPut Options Held
489K-
Vanguard Group Inc Valley Forge, PA20.5MShares$172 Million0.0% of portfolio
-
Black Rock Inc. New York, NY20MShares$167 Million0.0% of portfolio
-
Kynam Capital Management, LP Princeton, NJ8.93MShares$74.6 Million5.64% of portfolio
-
Avoro Capital Advisors LLC New York, NY8.7MShares$72.6 Million1.06% of portfolio
-
State Street Corp Boston, MA7.81MShares$65.2 Million0.0% of portfolio
About BIOCRYST PHARMACEUTICALS INC
- Ticker BCRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 185,944,992
- Market Cap $1.55B
- Description
- BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat...